Učitavanje...
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
Novel 2019 coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and coronavirus disease 2019 (COVID-19), the respiratory syndrome it causes, have shaken the world to its core by infecting and claiming the lives of many people since originating in December 2019 in Wuhan, China....
Spremljeno u:
| Izdano u: | Exp Biol Med (Maywood) |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283249/ https://ncbi.nlm.nih.gov/pubmed/33757336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370221999989 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|